Medical professional liability

Inpatient injectable medications and preventable adverse drug events: Healthcare and MPL costs

---

• Mid-year 2017 financial results for medical professional liability specialty writers

  By Eric J. Wunder, Bradley J. Parker | 18 September 2017

  This article summarizes some key financial results for a composite of medical professional liability specialty writers through the second quarter of 2017.

• First quarter financial results for medical professional liability specialty writers

  By Eric J. Wunder, Bradley J. Parker | 14 July 2017

  This article summarizes some key financial results for medical professional liability writers from the first quarter of 2017.

• Industry's profitability declines slightly while maintaining overall favorable results

  By Susan J. Forray, Chad C. Karls | 06 June 2017

  Surplus grew slightly in 2016, leaving the medical professional liability industry in a financial position roughly consistent with where it has been for the past half-decade.

• Patient compensation systems evolve: But are no less worrisome

  By Susan J. Forray, Eric J. Wunder | 28 April 2017

  This article focuses on some of the significant aspects of the patient compensation system (PCS) legislation and how they have varied by state and changed over time.

• 2016 year-end financial results for medical professional liability specialty writers

  By Eric J. Wunder, Bradley J. Parker | 12 April 2017

  This article concludes the seventh year of analyzing the quarterly and annual statutory financial results for a composite of medical professional liability (MPL) specialty writers.

• MPL actuarial valuations in M&As

  By Richard C. Frese, Andy Hoffman | 08 March 2017

  With mergers and acquisitions, it is critical that the medical professional liability insurance program be properly accounted for.

• Capitalizing on your actuarial report

  By Andy Hoffman, Richard C. Frese | 08 March 2017

  Insight and background on critical topics to discuss with an actuary to enhance recognition of your insurance program, better manage its liabilities, and maintain appropriate actuarial analysis for the needs of the program.

• A difficult time: MPL insurers navigate the future

  By Richard B. Lord, Stephen J. Koca | 27 September 2016

  How will medical professional liability insurers compete in a shrinking market and what will their role be?

• First quarter financial results for medical professional liability specialty writers

  By Bradley J. Parker, Eric J. Wunder | 13 July 2016

  The medical professional liability (MPL) market opens 2016 experiencing similar trends to those seen in recent years.

• A glass half empty or half full? Medical professional liability industry's profitability declines while maintaining overall favorable results

  By Chad C. Karls, Susan J. Forray | 24 June 2016

  Surplus grew slightly in 2015, leaving the medical professional liability industry in a financial position roughly consistent with where it has been since the end of 2011.

See More Articles